Trent Harold Spencer PhD

H. Trent Spencer, PhD, is an Associate Professor of Pediatrics and Director of the Gene and Cell Therapy Program in the Aflac Cancer and Blood Disorders Center. He is a Georgia Cancer Coalition Distinguished Scholar, and his areas of interest include gene therapy, stem cell biology, blood and marrow transplantation and immunotherapy. He is President and Co-founder of Expression Therapeutics, a privately owned biotechnology company that is developing therapies for hemophilia A patients. His laboratory has a significant interest in translational research focused on cancer and bleeding disorders, and he has been involved in the submission of several projects leading to investigational new drug applications.

Dr. Spencer is a member of the Discovery and Developmental Therapeutics research program at Winship. He is a member of the American Society of Cell and Gene Therapy and is a member of several committees within the society.